意大利PrEP:时机可能成熟但谁来买单?全国医生对抗逆转录病毒药物预防HIV感染态度的调查
一项关于意大利医生对PrEP(暴露前预防)知识与态度的全国性横断面调查数据集。

基本信息
资源简介
意大利PrEP:时机可能成熟但谁来买单?全国医生对抗逆转录病毒药物预防HIV感染态度的调查
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 2 个文件、合计 55.58 KB,主题涵盖 146 physicians、side effects、antiretroviral therapy、Italian National Health Organization、healthcare resources,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《PrEP in Italy: The time may be ripe but who''s paying the bill? A nationwide survey on physicians'' attitudes towards using antiretrovirals to prevent HIV infection》。配套论文《PrEP in Italy: The time may be ripe but who''s paying the bill? A nationwide survey on physicians'' attitudes towards using antiretrovirals to prevent HIV infection》发表于 PLOS ONE(2017),DOI:10.1371/journal.pone.0181433。源站首次发布:2017-07-20。
【数据内容】
源站原始描述:Several studies have demonstrated the efficacy of the oral pre-exposure prophylaxis (PrEP) with tenofovir (with or without emtricitabine) on preventing HIV-negative partners of HIV infected patients to become infected through sexual contacts. PrEP is already available in the United States and now is approved by European Medicine Agency. In this setting we would like to gauge physicians’ knowledge, acquaintance with and attitude to include PrEP in their clinical practice. A cross sectional survey…
【数据结构与技术规格】
文件数 2 个,合计 55.58 KB。S1 Table.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,18.03 KB。S1 File.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,37.55 KB。数据集 DOI:10.1371/journal.pone.0181433。
【主题与分类】
源站学科分类:Medicine、Biotechnology、Environmental Sciences not elsewhere classified、Biological Sciences not elsewhere classified、Science Policy、Infectious Diseases。主题标签:146 physicians、side effects、antiretroviral therapy、Italian National Health Organization、healthcare resources、United States、Italian physicians expert、SSN、PrEP impact、pre-exposure prophylaxis。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://plos.figshare.com/articles/dataset/PrEP_in_Italy_The_time_may_be_ripe_but_who_s_paying_the_bill_A_nationwide_survey_on_physicians_attitudes_towards_using_antiretrovirals_to_prevent_HIV_infection/5228464
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Di Biagio, Antonio; Riccardi, Niccolò; Signori, Alessio; Maserati, Renato; Nozza, Silvia; Gori, Andrea; et al. (2017). PrEP in Italy: The time may be ripe but who''s paying the bill? A nationwide survey on physicians'' attitudes towards using antiretrovirals to prevent HIV infection. PLOS ONE. Dataset
【使用注意】
· 源站最后修改于 2023-06-01,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:PrEP in Italy: The time may be ripe but who’‘s paying the bill? A nationwide survey on physicians’’ attitudes towards using antiretrovirals to prevent HIV infection
- DOI:10.1371/journal.pone.0181433
- 发布日期:2017-07-20
- 文件数:2 个
- 文件总体积:55.58 KB
- 源站页面:https://plos.figshare.com/articles/dataset/PrEP_in_Italy_The_time_may_be_ripe_but_who_s_paying_the_bill_A_nationwide_survey_on_physicians_attitudes_towards_using_antiretrovirals_to_prevent_HIV_infection/5228464
命令行下载
curl -L -o "S1 Table.docx" "https://ndownloader.figshare.com/files/8938108"
curl -L -o "S1 File.xlsx" "https://ndownloader.figshare.com/files/8938120"
文件清单
S1 Table.docx(18.03 KB)S1 File.xlsx(37.55 KB)
文件总体积 55.58 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Several studies have demonstrated the efficacy of the oral pre-exposure prophylaxis (PrEP) with tenofovir (with or without emtricitabine) on preventing HIV-negative partners of HIV infected patients to become infected through sexual contacts. PrEP is already available in the United States and now is approved by European Medicine Agency. In this setting we would like to gauge physicians’ knowledge, acquaintance with and attitude to include PrEP in their clinical practice. A cross sectional survey was conducted among Italian physicians expert on antiretroviral therapy. Out of 146 physicians, 35% of participants declared to be familiar with PrEP but only 46% of them believed that, currently, there are not enough reasons to make it available in Italy. 51% of physicians have already been attracted to prescribe it and 63.4% have been openly asked about PrEP. The main concerns noticed were: the risk of acquire other sexual transmitted diseases (STDs) (70% of physicians feared that PrEP could favor STDs spread), the potential harmful of PrEP if not adequately implemented and, especially the risk of possible side effects if not properly used. Nevertheless, 55.9% of participants believed that Health Authorities face an ethical obligation to make PrEP available as part of the strategies to protect from HIV transmission and half of the respondents asked for further researches to better define the role for PrEP. Attitudes regarding PrEP impact on Italian National Health Organization were also very interesting: 57.5% of participants did not believe that investing in PrEP would be an appropriate use of healthcare resources, while 70.6% affirmed that PrEP’s financial coverage should not be funded by the Italian National System of Health (SSN). This survey showed a high awareness of PrEP potential among Italian physicians coupled with a great deal of skepticism about how and if implementing it in clinical practice.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0181433(source: https://plos.figshare.com/articles/dataset/PrEP_in_Italy_The_time_may_be_ripe_but_who_s_paying_the_bill_A_nationwide_survey_on_physicians_attitudes_towards_using_antiretrovirals_to_prevent_HIV_infection/5228464)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




